Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name Ensartinib
Trade Name
Synonyms X-396
Drug Descriptions

Ensartinib (X-396) is a small molecule inhibitor of ALK, which inhibits downstream signaling and potentially leads to decreased growth of ALK-expressing tumors (PMID: 21613408, PMID: 31628085).

DrugClasses ALK Inhibitor 29
CAS Registry Number 1370651-20-9
NCIT ID C102754


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Bevacizumab + Carboplatin + Ensartinib + Pemetrexed Disodium Bevacizumab Carboplatin Ensartinib Pemetrexed Disodium 0 1
Carboplatin + Ensartinib Carboplatin Ensartinib 0 1
Cisplatin + Ensartinib Cisplatin Ensartinib 0 1
Denosumab + Ensartinib Denosumab Ensartinib 0 0
Durvalumab + Ensartinib Durvalumab Ensartinib 0 1
Ensartinib Ensartinib 27 8
Ensartinib + Sirolimus Ensartinib Sirolimus 1 0

Additional content available in CKB BOOST